MedPath

Slate Run Pharmaceuticals, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

55

FDA:55

Drug Approvals

olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide

Approval Date
May 14, 2025
FDA

gadobutrol

Approval Date
Apr 17, 2025
FDA

gadobutrol

Approval Date
Apr 17, 2025
FDA

gadoterate meglumine

Approval Date
Apr 16, 2025
FDA

gadoterate meglumine

Approval Date
Apr 16, 2025
FDA

Desvenlafaxine

Approval Date
Mar 26, 2024
FDA

Cisatracurium besylate

Approval Date
Mar 25, 2024
FDA

acyclovir

Approval Date
Feb 29, 2024
FDA

azithromycin dihydrate

Approval Date
Jan 29, 2024
FDA

Fluconazole

Approval Date
Jan 24, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy